Revance Therapeutics shares owned by DnB NOR Asset Management AS
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by DnB NOR Asset Management AS
from 13F filings
Historical chart of DnB NOR Asset Management AS investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by DnB NOR Asset Management AS consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by DnB NOR Asset Management AS
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $236k | 48k | 4.91 |
| 2023-12-31 | $305k | 35k | 8.79 |
| 2023-09-30 | $275k | 24k | 11.47 |
| 2023-06-30 | $551k | 22k | 25.31 |
| 2023-03-31 | $462k | 14k | 32.19 |
| 2022-12-31 | $218k | 12k | 18.46 |
More positions owned by DnB NOR Asset Management AS
Visa common (V)
View all positions for DnB NOR Asset Management AS